BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19777784)

  • 1. Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
    Ilboudo D; Simpore J; Sanou DS; Karou D; Sia DJ; Ouermi D; Bisseye C; Sagna T; Odolini S; Buelli F; Pietra V; Pignatelli S; Gnoula C; Nikiema JB; Castelli F
    Pak J Biol Sci; 2009 Jun; 12(12):908-13. PubMed ID: 19777784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa.
    Ilboudo D; Simpore J; Ouermi D; Bisseye C; Sagna T; Odolini S; Buelli F; Pietra V; Pignatelli S; Gnoula C; Nikiema JB; Musumeci S
    Braz J Infect Dis; 2010; 14(3):219-24. PubMed ID: 20835503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the Mother-to-Child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso.
    Ilboudo D; Karou D; Nadembega WM; Savadogo A; Djeneba O; Pignatelli S; Pietra V; Bere A; Simpore J; Traore AS
    Pak J Biol Sci; 2007 Sep; 10(17):2831-7. PubMed ID: 19090184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
    J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J; Pietra V; Savadogo A; Pignatelli S; Nikiema JB; Nadembega WM; Yara J; Zoungrana N; Bakouan D; Colizzi V; Castelli F; Musumeci S
    J Med Virol; 2006 Feb; 78(2):148-52. PubMed ID: 16372294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa.
    Linguissi LS; Bisseye C; Sagna T; Nagalo BM; Ouermi D; Djigma FW; Pignatelli S; Sia JD; Pietra V; Moret R; Nikiema JB; Simpore J
    Asian Pac J Trop Med; 2012 Dec; 5(12):991-4. PubMed ID: 23199720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.
    Sagna T; Bisseye C; Compaore TR; Kagone TS; Djigma FW; Ouermi D; Pirkle CM; Zeba MT; Bazie VJ; Douamba Z; Moret R; Pietra V; Koama A; Gnoula C; Sia JD; Nikiema JB; Simpore J
    Glob Health Action; 2015; 8():26065. PubMed ID: 25630709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
    BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatally cotransmitted human herpesvirus 6 is activated in children born with human immunodeficiency virus infection.
    Joshi PJ; Merchant RH; Pokharankar SL; Damania KS; Gilada IS; Mukhopadhyaya R
    J Hum Virol; 2000; 3(6):317-23. PubMed ID: 11100912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].
    Soubeiga ST; Compaore R; Djigma F; Zagre N; Assengone E; Traore L; Diarra B; Bisseye C; Ouermi D; Sagna T; Karou S; Pietra V; Simpore J
    Pan Afr Med J; 2015; 20():399. PubMed ID: 26301003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.